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consent patients who had been hospitalized for ACS and are on
Ticagrelor on discharge or on Ticagrelor therapy for ≤1 month will
be enrolled in the study and followed up for a period of 12 months.
Demographic data, diagnosis (type of ACS), management of ACS,
laboratory investigations, relevant history, and physical examina-
tion will be collated.
Results: Study is expected to ﬁll a signiﬁcant gap existing in our
knowledge to understand the usage pattern of Ticagrelor in real life
scenario in large number of ACS patients in India. The aim of this
national study is to understand the usage pattern (including the
durationof treatment) of Ticagrelor invariousACSpatientpopulation
undergoingPCI,CABG,ormedicalmanagement ina real-lifesetting in
India.Moreover,patientswithvarious risk factors (i.e. elderlypatients,
diabetes, renal impairment, smoking, GRACE risk score) and their
association with ACS and Ticagrelor usage will be measured.
The study started in May 2015 and approximately 100 patients
have been enrolled till date.
Conclusion: The multicenter national study will allow generating
real life evidence by involving patients from different geographies
and healthcare systems in India. The study is intended to provide
useful evidence of the Ticagrelor usage in variety of ACS patients in
actual hospital settings.
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Background: SYNTAX score is an objective scoring system to assess
severity and extent coronary artery disease. To evaluate the prognos-
tic value of the SYNTAX score in predicting in-hospital mortality in
coronary artery bypass patients, at a tertiary centre in India.
Methods: A cohort of 325 patients who underwent coronary artery
bypass surgery were included in this study from July 2012 to May
2014. They were divided into tertiles according to the SYNTAX
score (0–22, 23–33, and above 33). The endpoint was in-hospital
mortality.
Results: The mortality in SS tertiles were as follows: 0–22 = 6%; 23–
33 = 4.2%, and above 33 = 14.3%. There was signiﬁcant increase in
mortality in the third tertile ( p = 0.0297). SS above 33 had an odd's
ratio of 3.036 ( p = 0.018) for mortality.
Conclusion: Severity of coronary artery disease as measured by SS
of more than 33 is a signiﬁcant predictor of mortality after CAB
surgery.
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Background: Platelet activation and aggregation has been
implicated in the pathogenesis of atherosclerosis and in the
development of acute thrombotic event. Platelet volume is a mar-
ker of platelet activation and function, and is measured using
mean platelet volume (MPV).
Aim: To investigate the relationship between MPV and angio-
graphic severity of coronary artery disease in terms of SYNTAX
score, both in stable angina and acute coronary syndromes.
Methods: In this study, a total of 160 patients were evaluated who
presented with suspected CAD on clinical grounds. All patients
underwent routine biochemical examination, complete blood
count, and coronary artery angiography using standardized pro-
tocol. SYNTAX score was calculated using online software and
correlation between MPV and coronary lesion severity was ana-
lysed using statistical software.
Results: Out of 160 patients, 37 (23.12%) patients presented with
CSA and 104 (65%) patients with ACS; out of which 29 (18.12%)
patients diagnosed with UA or NSTEMI and 75 (46.87%) patients
with STEMI; 19 (11.87%) patients had normal coronary angio-
gram, allocated to control group. Mean age of the CSA patients
was 58.16  11.48 years, while in UA&NSTEMI and STEMI group it
was 52.10  8.52 years and 53.99  11.83 years, respectively.
51.21  9.43 years was the mean age in control group. 129
(80.6%) patients were male and 31 (19.4%) patients were female.
ACS patients, i.e. UA&NSTEMI and STEMI patients had signiﬁ-
cantly higher MPV value than CSA and control group (8.86  1.07,
8.83  0.73 fL vs 8.42  0.81, 7.50  0.18 fL; p < 0.001). Mean SYN-
TAX score in CSA group was 16.54  8.10 in male and 17.83  7.41
in female; in UA&NSTEMI group, 19.27  9.85 in male and 9.92
 9.89 in female with p value of 0.049. In STEMI group mean
SYNTAX score was 19.73  7.27 in male and 17.75  2.79 in
female. In low SYNTAX score group MPV values were signiﬁ-
cantly more in UA&NSTEMI patients and STEMI patients than
CSA and control group (8.37  0.76, 8.59  0.62 fL vs 8.09  0.62,
7.50  0.18 fL; p < 0.001). In intermediate and high SYNTAX score
group MPV did not differ signiﬁcantly. MPV was signiﬁcantly
more in intermediate and high SYNTAX score category than low
SYNTAX score, in all the three study groups. According to Pear-
son correlation analysis there was large positive relationship
between MPV and SYNTAX score in all the three study groups.
ROC curve analysis showed cut-off values of MPV for predicting
the severity of SYNTAX score, were >7.7 fL for CSA group and
>8 fL for ACS patients.
Conclusion: We found that higher MPV values are signiﬁcantly
associated with acute coronary syndromes than stable angina;
higher the MPV value more severe and complex is the coronary
artery disease, as demonstrated by the SYNTAX score analysis.
MPV can be considered a marker of platelet reactivity or a risk
factor for CAD. Large scale, randomized controlled trials are
needed for further clariﬁcation.
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Background: Postinfarction angina is not an uncommon complica-
tion after myocardial infarction (MI). Because of its high risk score
(Unstable Angina class III, Risk score 9 if rest angina <48 h post MI)
guidelines recommend early intervention in these patients. How-
ever, ﬁnancial constraints and lack of wide insurance coverage in
developing countries prohibit intervention in these patients. That
is why we analysed the addition of tiroﬁban (GpIIb/IIIa inhibitor)
which acts by inhibiting platelet aggregation a key mechanism in
postinfarction angina.
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